 |
Previous Article | Next Article 
The Journal of Neuroscience, May 15, 1998, 18(10):3606-3619
The Glutamate Transporter EAAT4 in Rat Cerebellar Purkinje Cells:
A Glutamate-Gated Chloride Channel Concentrated near the Synapse in
Parts of the Dendritic Membrane Facing Astroglia
Yvette
Dehnes,
Farrukh A.
Chaudhry,
Kyrre
Ullensvang,
Knut P.
Lehre,
Jon
Storm-Mathisen, and
Niels C.
Danbolt
Department of Anatomy, Institute of Basic Medical Sciences,
University of Oslo, N-0317 Oslo, Norway.
 |
ABSTRACT |
Antibodies to an excitatory amino acid transporter (EAAT4) label a
glycoprotein of ~65 kDa strongly in the cerebellum and weakly in the
forebrain. Cross-linking of cerebellar proteins with
bis(sulfosuccinimidyl) suberate before solubilization causes dimer
bands of EAAT4 and both dimer and trimer bands of the other glutamate
transporters GLAST (EAAT1) and GLT (EAAT2) to appear on immunoblots. In
contrast to GLAST, GLT, and EAAC (EAAT3), EAAT4 is unevenly distributed
in the cerebellar molecular layer, being strongly expressed in
parasagittal zones. It is located in cerebellar Purkinje cells, and the
highest concentrations are seen in ones expressing high levels of
zebrin II (aldolase C). The labeling of Purkinje cell spines and thin
dendrites is stronger than that of large diameter dendrites and cell
bodies. EAAT4 is present at low concentrations in the synaptic
membrane, but is highly enriched in the parts of the dendritic and
spine membranes facing astrocytes (which express GLAST and GLT)
compared with parts facing neuronal membranes, suggesting a functional
relationship with glial glutamate transporters. The presence of EAAT4
in intracellular cisterns and multivesicular organelles may reflect
turnover of transporter in the plasma membrane. The total Purkinje cell
spine surface and the EAAT4 concentration were found to be 1.1 m2/cm3 and 0.2 mg/cm3, respectively, in the molecular layer,
corresponding to 1800 molecules/µm2. The
juxtasynaptic location of EAAT4 may explain electrophysiological observations predicting the presence of a neuronal glutamate
transporter near the release site at a Purkinje cell spine synapse.
EAAT4 may function as a combined transporter and inhibitory glutamate receptor.
Key words:
neurotransmitter transport; neurons; glutamate uptake; antipeptide antibodies; immunocytochemistry; cerebellum
 |
INTRODUCTION |
The extracellular concentration of
the excitatory transmitter glutamate is kept low by transporter
proteins located in the plasma membranes. These transporters (for
review, see Danbolt, 1994 ; Robinson and Dowd, 1997 ) are essential for
securing a high signal-to-noise ratio in synaptic transmission and for
preventing harmful receptor overstimulation. The complexity of the
uptake system suggests that its functions are more refined than simple transmitter removal. Five different glutamate (excitatory amino acid)
transporters have been cloned so far: GLAST (EAAT1) (Storck et al.,
1992 ; Tanaka et al., 1993 ), GLT (EAAT2) (Pines et al., 1992 ), EAAC
(EAAT3) (Kanai and Hediger, 1992 ), EAAT4 (Fairman et al., 1995 ), and
EAAT5 (Arriza et al., 1997 ). The proteins GLT and GLAST have only been
demonstrated in astrocytes in the brain (Danbolt et al., 1992 ; Levy et
al., 1993 ; Chaudhry et al., 1995 ; Ginsberg et al., 1995 ; Lehre et al.,
1995 ; Schmitt et al., 1996 , 1997 ). EAAC is neuronal and probably
predominantly postsynaptic (Rothstein et al., 1994 ). EAAT4 is a
neuronal postsynaptic glutamate transporter in Purkinje cell spines
(Yamada et al., 1996 ; Nagao et al., 1997 ). The expression of the
transporters is highly differentiated (Chaudhry et al., 1995 ; Lehre et
al., 1995 ) and regulated (Ginsberg et al., 1995 ; Levy et al., 1995 ;
Gegelashvili et al., 1996 , 1997 ), and their transport activities are
modulated by fatty acids (Barbour et al., 1989 ; Trotti et al., 1995 ;
Zerangue et al., 1995 ; Kataoka et al., 1997 ), oxidation of sulfhydryl
groups (Trotti et al., 1996 , 1997 ), and phosphorylation (Casado et al.,
1993 ; Conradt and Stoffel, 1997 ). In addition to being cotransporters,
they also behave as glutamate-gated chloride channels; this property is
particularly prominent in EAAT4 and EAAT5 (Fairman et al., 1995 ;
Vandenberg et al., 1995 ; Wadiche et al., 1995a ,b ; Arriza et al., 1997 ).
The idea that the transporters are actively involved in the regulation
of synaptic transmission is supported experimentally (Barbour et al.,
1994 ; Mennerick and Zorumski, 1994 ; Tong and Jahr, 1994 ; Takahashi et
al., 1995 , 1996 ; Clements, 1996 ; Diamond and Jahr, 1997 ; Kataoka et
al., 1997 ; Otis et al., 1997 ).
Recent electrophysiological findings suggest that a neuronal glutamate
transporter with a high chloride conductance (i.e., such as EAAT4) is
located postsynaptically close to the release site of climbing fiber
synapses onto cerebellar Purkinje cells (Takahashi et al., 1996 ; Otis
et al., 1997 ). Tanaka and coworkers (1997) report that EAAT4 is
localized extrasynaptically on Purkinje cell spines. Here we
demonstrate by electron microscopic quantification of gold-labeled
antibody binding on ultrathin sections that EAAT4 is present in the
synaptic and perisynaptic membranes. The highest concentrations,
however, are found on the parts of the Purkinje cell spines and their
parent thin dendrites that are ensheathed by astrocytes. Lower
concentrations are found on the parts that are in contact with neurons.
It has been reported (Nagao et al., 1997 ) that EAAT4 is concentrated in
parasagittal zones, resembling those expressing zebrin (Brochu et al.,
1990 ). Here we demonstrate that the highest EAAT4 expression is found
in the zebrin plus Purkinje cells and that GLT, GLAST, and EAAC, in
contrast to EAAT4, do not exhibit parasagittal banding in the
cerebellar cortex. We show further that EAAT4, like GLT, GLAST, and
EAAC, is an oligomeric glycoprotein, and we present the quantification
of the tissue content of a glutamate transporter in absolute terms.
 |
MATERIALS AND METHODS |
Materials. SDS of high purity (>99% C12
alkyl sulfate) and bis(sulfosuccinimidyl) suberate were from Pierce
(Rockford, IL). Nitrocellulose sheets (0.22 µm pores, 100%
nitrocellulose) and electrophoresis equipment were from Hoefer
Scientific Instruments (San Francisco, CA).
N,N'-methylene-bisacrylamide, acrylamide, ammonium
persulfate, N,N,N',N'-tetramethylethylenediamine, and alkaline phosphatase substrates (nitroblue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate) were from Promega (Madison, WI).
Protein A-Sepharose Fast Flow and Sephadex G-50 fine were from
Pharmacia (Uppsala, Sweden). Molecular mass markers for SDS-PAGE,
biotinylated anti-rabbit, anti-sheep, and anti-mouse immunoglobulins,
streptavidin-biotinylated horseradish peroxidase complex, and colloidal
gold-labeled anti-rabbit and anti-mouse immunoglobulins were from
Amersham (Buckinghamshire, UK). Paraformaldehyde and glutaraldehyde EM
grade were from TAAB (Reading, UK). Lowicryl HM20 was from Electron
Microscopy Sciences (Fort Washington, PA). Pure GLT glutamate
transporter protein was a gift from Dr. K. P. Lehre. Alkaline
phosphatase-conjugated monoclonal antibodies to rabbit and sheep IgG,
bovine serum albumin (BSA),
3-[(3-cholamido-propyl)dimethylammonio]-1-propanesulfonate (CHAPS), dithiothreitol (DTT), EDTA, HEPES, human serum albumin (HSA),
phenylmethanesulfonyl fluoride (PMSF), Trizma base, Tris-HCl, and wheat
germ agglutinin (WGA) were obtained from Sigma (St. Louis, MO). WGA was
immobilized to agarose as described previously (Danbolt et al., 1992 ).
Other reagents were obtained from Fluka (Buchs, Switzerland).
Antibodies. Antipeptide antibodies against EAAT4 were
prepared as described (Lehre et al., 1995 ; Danbolt et al., 1998 ) by immunizing rabbits or sheep with synthetic peptides (D154 and D537, see
below) coupled to keyhole limpet hemocyanin with glutaraldehyde. The
other glutamate transporter antibodies used (see below) in this study
were from the same purified batches as published previously (Haugeto et
al., 1996 ). The peptides representing parts of GLAST (Storck et al.,
1992 ), GLT (Pines et al., 1992 ), EAAC1 (Kanai and Hediger, 1992 ), and
human EAAT4 (Fairman et al., 1995 ) are referred to by capital letters
"A", "B", "C," and "D," respectively, followed by
numbers indicating the corresponding amino acid residues in the
sequences (given in parentheses): A1-25
(MTKSNGEEPRMGSRMERFQQGVRKRC), A522-541 (PYQLIAQDNEPEKPVADSET), B12-26
(KQVEVRMHDSHLSSE), B493-508 (YHLSKSELDTIDSQHR), C510-524
(VDKSDTISFTQTSQF), D154-171 (CHPGKGSKEGLHREGRIET), and D537-564
(CPSLGKPYKSLMAQEKGASRGRGGNESAM). The corresponding anti-peptide
antibodies are referred to as anti-A1 (rabbit 20492), anti-A522 (rabbit 68488), anti-B12 (rabbit 68518), anti-B493 (rabbit 84946), anti-C510 (rabbit 69738), anti-D154 (rabbit 26727), or anti-D537 (rabbit 26900, sheep 4036). Mouse monoclonal antibody (Brochu
et al., 1990 ) to zebrin II/aldolase C (Ahn et al., 1994 ) was obtained
from R. Hawkes (University of Calgary, Alberta, Canada).
Animals. Wistar rats from Møllegaard Hansen were kept in
the animal facility at the Institute of Basic Medical Sciences. All handling of animals was according to European regulations and was under
veterinary supervision. The rats were killed by stunning and
decapitation.
WGA-lectin affinity chromatography of glutamate
transporters. Glutamate transporters were partially purified from
brain tissue as described (Danbolt et al., 1990 , 1992 ) by lectin
affinity chromatography on immobilized WGA. Bound glycoproteins were
eluted with 110 mM N-acetylglucosamine in 20 mM NaPi (sodium phosphate buffer, pH 7.4) containing 500 mM NaCl and 20 mM CHAPS. The eluted proteins were mixed with SDS-sample buffer (70 mM SDS, 62.5 mM Tris-HCl, pH 6.8, 0.3 M sucrose, 10 µg/ml
bromophenol blue) and electrophoresed (see below).
Cross-linking of membrane proteins. This was performed
exactly as described (Haugeto et al., 1996 ). The cerebella of Wistar rats were dissected out and immediately homogenized in 10-20 vol of
ice-cold hypotone solution (5 mM EDTA, 1 mM
PMSF, and 5 mM DTT). The homogenate was centrifuged (18,000 rpm, 39,000 × g, 4°C, 15 min), and the membrane
pellets were resuspended in buffer (150 mM NaCl, 100 mM Na-HEPES, pH 7.5, 5 mM EDTA, 1 mM PMSF, 5 mM DTT) to a final protein
concentration of ~0.5 mg/ml and divided into aliquots. A
cross-linker, bis(sulfosuccinimidyl) suberate, was immediately added to
final concentrations of 0.3, 1, 3, 10, or 30 mM from a
freshly prepared 100 mM stock solution in 20 mM HCl. After incubation (12 min, room temperature, end-over-end mixing),
the reaction was terminated by adding 2 M Tris-HCl, pH 9. Then SDS-sample buffer (see above) was added to the mixtures. The
mixtures were gel-filtered (Trotti et al., 1995 ) on Sephadex G-50 fine
spin columns equilibrated with the above SDS-sample buffer (containing
5 mM DTT) and run on SDS-PAGE (see below).
Electrophoresis and blotting. SDS-PAGE was performed as
described (Laemmli, 1970 ; Lehre et al., 1995 ) with separating gels consisting of 7.5 or 10% acrylamide. The molecular mass markers were
used in nonreduced form. After electrophoresis the proteins either were
silver-stained (Danbolt et al., 1990 ) or electroblotted onto
nitrocellulose membranes (Towbin et al., 1979 ; Lehre et al., 1995 ). The
blots were immunostained with alkaline phosphatase-conjugated secondary
antibodies (Lehre et al., 1995 ), except that 1% BSA was replaced with
4% (w/v) nonfat dry milk as blocking agent. This replacement was found
to give lower background and stronger signal (data not shown).
Immunoisolation of EAAT4. The rabbit anti-D537 antibodies (1 mg) were covalently immobilized on 1.5 ml protein A-Sepharose Fast Flow
as described (Danbolt et al., 1992 ). Fifteen Wistar rats were killed by
stunning and decapitation. The cerebella were immediately homogenized
in 20 vol of ice-cold hypotonic solution (5 mM EDTA and 1 mM PMSF) and centrifuged (18000 rpm, 20 min, 4°C; Beckman
JA-20 rotor). The pellet was solubilized in 15 vol of buffer to final
concentrations (2% cholate, 300 mM NaCl, 100 mM NaPi, pH 7.4, and ammonium sulfate to 10% saturation).
After incubation on ice (15 min) and a brief sonication to reduce
viscosity, unsolubilized material was removed by centrifugation as
above. The supernatant was diluted in 3 vol of buffer with 1% cholate and incubated with the immobilized antibodies (end-over-end, 1.5 hr,
4°C). After they were washed with buffer, the precipitated proteins
were released from the Sepharose beads by low pH buffer (0.1% Triton
X-100 and 150 mM NaCl in 0.3 M glycine-HCl, pH
2.0). The eluted proteins were desalted on Sephadex G-50 and
concentrated on DEAE-cellulose. This resulted in a highly purified but
not homogeneous preparation (see Fig. 3). Consequently, the protein concentration determined by the bicinchoninic acid protein assay (Smith
et al., 1985 ) represented an overestimation of the true content of
EAAT4. The purification procedure was repeated once. To achieve a
better estimate of the EAAT4 content in the two purified preparations,
the preparations were subjected to SDS-PAGE, together with a highly
purified preparation of GLAST, and silver-stained. One of the
preparations is shown in Figure 3. The gels were then scanned and
analyzed by densitometer [the Discovery Series equipped with the
Quantity One program (pdi, Inc., Huntington Station, New York) run on a Sparc computer (Sun Microsystems, Inc.)], as explained in the legend to Figure 3.
Quantification of EAAT4 in cerebellum. Cerebella from three
male 8- to 9-week-old Wistar rats (a, b, and c) were homogenized in 10 vol of 50 mM NaPi, pH 7.4, with SDS (10 mg/ml), and
sonicated briefly to reduce viscosity. Parts of the molecular layer of
vermis (lobulus 6) were collected from another three rats (d, e, and f;
7- to 8-week-old rats). The tissue was treated as above, and the
protein concentrations were determined in all six samples with the
method of Lowry et al. (1951) . These extracts contained all the tissue
proteins. The immunoreactivities per micrograms of protein in these
samples were compared with the immunoreactivities of the two purified
preparations of EAAT4 by quantitative immunoblotting. Each gel had 20 lanes that were loaded with 3, 10, and 20 µg of protein from each of
rats a-c and 1.5 and 5 (or 3 and 7.5) µg of protein from rats d-f.
The rest of the lanes were loaded with 0-50 ng EAAT4 protein from one
of the two purified preparations (see preceding paragraph above).
The electrophoresis was performed as described above, and the
quantitative immunoblotting was performed exactly as had been reported
previously (Levy et al., 1995 ). Briefly, the blots were blocked with
gelatin in PBS (140 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, and 8.1 mM Na2HPO4, pH 7.4),
incubated with 0.2 µg/ml IgG anti-D537, washed, blocked, incubated
(90 min) with iodinated protein-A (400-1000 cpm/µl) in the same
solution, washed, and dried. The blots were then autoradiographed.
After the development the x-ray films were aligned with the blots to
enable identification of the bands corresponding to EAAT4 on the blots.
The parts of the blots containing the bands were cut out, and the
radioactivity was determined. Pieces of nitrocellulose outside the
EAAT4 protein bands were used as background.
The values obtained from the lanes containing known amounts of EAAT4
protein were curve-fitted using the Fig.P program from Biosoft
(Cambridge, UK). Approximation to an asymmetric sigmoid curve gave a
slightly better fit to the data than linear regression. The
immunoreactivities in the unknown samples were converted to nanograms
of EAAT4 protein using the former standard curve.
Protein determination. Concentrations of membrane protein
were determined with the Lowry (Lowry et al., 1951 ) or bicinchoninic acid (Smith et al., 1985 ) protein assays using BSA as standard. Purified IgG was quantified spectrophotometrically at 280 nm using bovine IgG as standard. The concentration of immunoisolated EAAT4 was
determined densitometrically on silver-stained polyacrylamide gels
using purified GLAST or GLT protein as standard (see Fig. 3).
Estimation of spine surface area. Male 8-week-old Wistar
rats were perfusion-fixed (Lehre et al., 1995 ) with a mixture of 2.5%
glutaraldehyde and 1% freshly depolymerized paraformaldehyde in 0.1 M NaPi. Pieces of fixed tissue were cut out from the
stratum moleculare of vermis of the cerebellum (lobulus 6) and embedded in Durcupan as described (Lehre et al., 1995 ). Two sectioning angles
were chosen according to the vertical sectioning method of Baddeley et
al. (1986) . Electron micrographs were taken of serial sections (five or
six sections in each of two series) so that each structure could be
identified at several sectioning levels. Spines were identified
according to Spacek and Hartmann (1983) and Spacek (1985a ,b ).
Micrographs were printed at 55,000× magnification, and a test system
similar to that of Baddeley et al. (1986 , their Fig. 7a)
with 2.0 cm length cycloids was used. The direction of the parallel
fibers was chosen as vertical axis. Two sectioning angles perpendicular
to each other were used.
Light and electron microscopic immunocytochemistry: pre-embedding
peroxidase. This was done largely as described (Lehre et al.,
1995 ). Briefly, five Wistar rats were deeply anesthetized, fixed by
transcardiac perfusion (at room temperature by means of a peristaltic
pump at a flow rate of ~50 ml/min; 500 ml/rat) with a mixture of 4%
formaldehyde, 0.2% picric acid, and 0.05% glutaraldehyde in 0.1 M NaPi (Somogyi and Takagi, 1982 ). Then the brains were
taken out, immersed in the same fixative for 2 hr or overnight (4°C),
and stored in the cold fixative diluted 10 times with buffer. In one
additional case, the cerebellum was immersion-fixed with only 4%
formaldehyde in 0.1 M NaPi overnight. Free-floating
Vibratome sections (40-µm-thick) were treated with 1 M
ethanolamine-HCl, pH 7.4, blocked with newborn calf serum or 4% nonfat
dry milk and incubated with primary antibodies overnight, followed by
secondary antibodies and development with the
biotin-streptavidin-peroxidase system and diaminobenzidine. When
stated in the text or figure legend, 0.5% (v/v) Triton X-100 was added
during the processing. For electron microscopy the sections (processed
without Triton X-100) were treated with 1% OsO4 in 0.1 M NaPi, dehydrated in graded ethanols and propylene oxide,
and embedded in Durcupan ACM. Ultrathin sections were cut and lightly
contrasted with 10 mg/ml uranyl acetate for 11 min and with 3 mg/ml
lead citrate for 70 sec. Control sections incubated with preimmune IgG
instead of anti-peptide antibodies, or with antibodies preabsorbed with the peptide used for immunization, showed no labeling.
Quantitative electron microscopic immunocytochemistry:
postembedding immunogold. The procedures in principle were
according to Chaudhry et al. (1995) . For best preservation of
ultrastructure, two rats were perfusion-fixed (as above) with a
solution of 2.5% glutaraldehyde and 1% formaldehyde (formaldehyde was
freshly prepared by depolymerizing paraformaldehyde; glutaraldehyde was
added from a 25% solution just before use) in 0.1 M NaPi.
For best preservation of antigenic epitopes, three rats were fixed
using pH-shift formaldehyde (Berod et al., 1981 ) combined with picric
acid (Somogyi and Takagi, 1982 ): 4% formaldehyde and 0.2% picric acid
in 0.1 M sodium acetate buffer, pH 6.0 (200 ml, 5 min),
followed by the same fixatives in 0.1 M sodium carbonate
buffer, pH 10.5 (400 ml, 20 min) (Marcos et al., 1997 ). Consistent
results were obtained with the two fixation methods. For EAAT4 the
signal was almost equally good with both fixatives; hence the
glutaraldehyde mixture, which gave somewhat better morphology, was used
for illustration and quantitative analysis. For the monoclonal antibody
to zebrin only the pH-shift gave a sufficiently good signal.
Small rectangular pieces (typically ~0.5 mm × 0.5 mm × 1 mm) were cryoprotected by immersing in 10% and subsequently 20%
glycerol in 0.1 M NaPi for ~0.5 hr, and then in 30%
glycerol in 0.1 M NaPi overnight at 4°C. The samples were
then plunged into liquid propane cooled to 190°C by liquid nitrogen
in a Universal Cryofixation System KF80 (Reichert-Jung, Wien, Austria).
The tissue blocks were moved to a precooled Cryo Substitution Apparatus
CS Auto or AFS (Reichert) by a precooled forceps. For
freeze-substitution (Müller et al., 1980 ) the tissue samples were
immersed in a solution of anhydrous methanol and 0.5% uranyl acetate
(for en bloc fixation) overnight at 90°C. The temperature was then
raised stepwise in 4°C increments per hour from 90 to 45°C,
where it was kept for the subsequent steps. The tissue samples were
then washed several times with anhydrous methanol to remove residual
water and uranyl acetate. The infiltration in Lowicryl HM20 went
stepwise from Lowicryl/methanol 1:2, 1:1, and 2:1 (1 hr each) to pure
Lowicryl (overnight). For polymerization, the tissues were placed in a precooled embedding mall, and the polymerization was catalyzed by
ultraviolet light of 360 nm wavelength for 2 d at 45°C
followed by 1 d at room temperature. Ultrathin sections were cut
by a diamond knife on a Reichert-Jung ultramicrotome and mounted on
nickel grids using an adhesive pen (David Sangyo).
The grids with the ultrathin sections were processed at room
temperature in solutions containing 50 mM Tris-HCl buffer,
pH 7.4, 0.15 M NaCl, and 0.1% Triton X-100 (TBST), with
additions as stated. The sections were first washed in TBST containing
0.1% sodium borohydride and 50 mM glycine for 10 min,
followed by TBST containing 3% human serum albumin (HSA) for 10 min.
They were then incubated overnight with primary antibody diluted in
TBST containing 3% HSA, and subsequently washed in TBST containing 3%
HSA. The anti-D537 antibody from rabbit was applied to the sections at
a final concentration of 16.6 µg/ml; the use of higher concentrations
resulted in no net gain in signal. The anti-zebrin antibody (mouse
hybridoma supernatant) was diluted 1:2. Control nonimmune IgGs used at
the same concentrations as the anti-transporter antibodies, or antibody
preabsorbed with D537 peptide, gave essentially no labeling. Bound
antibodies were visualized by incubation for 2 hr with goat anti-rabbit
or anti-mouse immunoglobulin labeled with 15 or 10 nm colloidal gold
(GAR15 or GAM10, Amersham). In some experiments sections were
double-labeled with both the anti-D537 and anti-zebrin antibodies,
followed by GAR15 and GAM10. The colloidal gold-labeled secondary
antibodies were diluted 1:20 in TBST and spun at 1000 rpm for 10 min
before use to sediment aggregated gold particles. After they were
washed in purified water, the sections were dried and then contrasted
by immersion in a saturated solution of uranyl acetate (4-10 min),
followed after rinsing in purified water by a saturated solution of
lead citrate (30-60 sec) and another water rinse.
The ultrathin sections were observed in a Philips CM10 electron
microscope. Pictures were taken (usually) at 6400× primary magnification and printed at a final magnification of 48,500×. Tissue
components were identified according to Palay and Chan-Palay (1974) .
The lengths of stretches of transected membrane were measured by means
of a digitizing tablet, and the densities of the associated gold
particles (manually counted) were computed by means of the data
programs MORFOREL (Blackstad et al., 1990 ) and PALIREL (H. K. Ruud
and T. W. Blackstad, unpublished data). Particles within 45 nm on
either side of the cytosolic border of the plasmalemma were recorded
(Chaudhry et al., 1995 ). In the present material >95% of all
particles were within this distance, and 40% were between 0 and 20 nm
on the intracellular side. ANOVA statistical analysis (Newman-Keuls
test, or when stated Wilcoxon matched-pairs test) and fitting to the
Poisson distribution were performed by means of the STATISTICA
package.
 |
RESULTS |
Immunoblotting
Antisera from rabbits immunized with synthetic peptides
corresponding to parts of human EAAT4 were affinity-purified against the respective peptides and tested for specificity on Western blots of
SDS-solubilized whole tissue. The antibodies labeled one broad fuzzy
band around 65 kDa (Fig. 1). The labeling
disappeared when the antibodies were preabsorbed with the respective
peptides (data not shown). The immunoreactivity was much stronger on
immunoblots of glycoproteins (Fig. 1, lanes 4-6)
isolated by WGA (lectin) affinity chromatography than on immunoblots of
crude extracts (lanes 1-3), suggesting that EAAT4, like the
other three glutamate transporters (Haugeto et al., 1996 ), is
glycosylated. The labeling was far stronger on blots containing
cerebellar proteins (rat or human) than on blots containing forebrain
proteins (data not shown). The specificity of the signal in the
forebrain was verified in the following way. The immunoreactive protein
was isolated with sheep anti-D537, run on SDS-PAGE, and immunoblotted
with rabbit anti-D154 (data not shown) and rabbit anti-D537 (Fig. 1, lanes 8-9). The anti-D537 antibodies from rabbit 26900 appeared to be the most potent and specific and were used when not
stated otherwise.

View larger version (63K):
[in this window]
[in a new window]
|
Figure 1.
The specificity of the EAAT4 antibodies as
demonstrated by immunoblotting of electrophoretically separated
proteins. Lanes 1-3, 7: Cerebellar proteins were
solubilized with SDS and immunoblotted. Lanes 4-6:
Glycoproteins were isolated from CHAPS-solubilized cerebellum by lectin
affinity chromatography and immunoblotted. Lanes 8-9:
EAAT4 was isolated from rat forebrain (lane 8) or rat
cerebellum (lane 9) by immunoabsorption on protein
G-Sepharose-immobilized sheep anti-D537 antibodies as described
(Haugeto et al., 1996 ). The blots were incubated with 200 ng/ml sheep
anti-D537 antibodies (lanes 1, 4), 200 ng/ml
rabbit anti-D537 antibodies (lanes 2, 5), 10 µg/ml
anti-D154 antibodies (lanes 3, 6), or 1 µg/ml
rabbit anti-D537 antibodies (lanes 7-9). The amounts of
protein in each lane were 14 µg in lanes 1-3, 2 µg in lanes 4-6,
and 8 µg in lane 7. The amounts applied in lanes 8-9 were not
determined. Note that EAAT4 is also present in the forebrain because it
could be immunoisolated from the forebrain (lane 8),
although the amount recovered was much smaller than that recovered from
the cerebellum (lane 9). The arrowheads
indicate the monomer band of EAAT4.
|
|
Although fresh SDS extracts gave rise to EAAT4 monomers on the
immunoblots even under nonreducing conditions, oxidation of the
proteins led to the appearance of oligomers. Cross-linking of proteins
in the membranes with bis(sulfosuccinimidyl) suberate (Fig.
2) before solubilization made bands
corresponding to dimers visible on the blots. Trimers were not detected
for EAAT4, although they have been reported previously for GLAST and
GLT (Haugeto et al., 1996 ).

View larger version (108K):
[in this window]
[in a new window]
|
Figure 2.
Immunoblots of glutamate transporters cross-linked
before solubilization. Membranes from fresh rat cerebellum were
incubated with 5 mM DTT and 0 (lane 1), 0.3 (lane 2), 1 (lane 3), 3 (lane
4), or 10 mM (lane 5)
bis(sulfosuccinimidyl) suberate, solubilized in SDS, run on SDS-PAGE,
and immunoblotted with 200 ng/ml anti-D537 antibodies to EAAT4
(A), 200 ng/ml anti-A522 antibodies to GLAST
(B), or 100 ng/ml anti-B12 antibodies to GLT
(C). The highest cross-linker concentrations
resulted in insoluble aggregates and lower immunoreactivity on the
blots. Six micrograms of protein were applied in each lane. Note that
EAAT4 (A) forms dimers, whereas GLAST
(B) and GLT (C) form dimers
and trimers.
|
|
Quantification of EAAT4 protein in the cerebellum
When both a pure protein and specific antibodies to the same
protein are available, it is possible to measure the tissue
concentration of this protein simply by comparing the immunoreactivity
of the tissue with that of known amounts of the pure protein by
immunoblotting. Because SDS solubilizes brain tissue completely (the
brain goes into a clear solution), representative brain extracts
containing all the tissue components can be prepared.
Thus, to quantify EAAT4 we needed purified EAAT4 protein of known
concentration. Synthetic peptides could not be used as a substitute for
EAAT4 protein because antibodies raised against synthetic peptides
often react more strongly with the peptides than with the native
proteins (Lehre et al., 1995 ; Danbolt et al., 1998 ). We therefore
isolated EAAT4 from the rat cerebellum using anti-D537 antibodies
covalently immobilized on agarose (Fig. 3). Then, the immunoreactivities of this
purified EAAT4 protein and of SDS solubilized whole-tissue proteins
(entire cerebellum or only the molecular layer) were compared on
immunoblots. Based on the content of EAAT4 in the purified preparation
(two separate preparations gave consistent results), it was found that
the immunoreactivity per microgram of protein of cerebellar
whole-tissue extracts was 0.065 ± 0.003% (mean ± SEM of
values from three rats) of that of pure EAAT4 protein. Values three
times higher (0.20 ± 0.007%) were obtained when the purified
EAAT4 protein was compared with whole-tissue protein from the molecular
layer of vermis (lobulus 6). (Because EAAT4 is virtually Purkinje cell
specific, these data imply that the molecular layer represents about
one-third of the entire adult rat cerebellum or ~0.1
cm3.) Because the protein content of brain tissue is
~0.1 gm/cm3, 1 µm3 cerebellum
and 1 µm3 cerebellar molecular layer contain
~0.065 and 0.20 fg of EAAT4, respectively.

View larger version (47K):
[in this window]
[in a new window]
|
Figure 3.
Quantification of immunoisolated EAAT4 protein.
Highly purified GLAST protein (300, 100, and 60 ng in lanes
1-3, respectively) and a purified preparation of EAAT4 (300, 600, and 1000 ng total protein in lanes 4-6,
respectively) were subjected to SDS-PAGE and silver-stained. The
optical densities of the GLAST bands (a) on this
particular gel were 4.29, 1.45, and 0.97, whereas the optical densities
for the EAAT4 band (b) were 1.14, 2.35, and 3.46 corresponding to 76, 140, and 220 ng EAAT4, respectively.
|
|
Determination of spine surface area in the cerebellum
Spines were identified in electron micrographs taken from serial
sections, so that each structure could be identified at several sectioning levels. This approach allowed most structures to be identified. Still a few unidentified structures remained. Because some
of these may have been spines, the spine surface area may be slightly
underestimated. Furthermore, EAAT4 is also present in other parts of
the Purkinje cell membrane, although at lower concentrations (see Fig.
11). Thus, EAAT4 is distributed over a larger surface than that
measured here. On the other hand, the EAAT4-poor part of the spine
surface contacting neurons represents ~25% of the total spine
surface (Spacek, 1985b ). The stated sources of over- and
underestimation of the EAAT4-containing membrane area are thought to
roughly cancel each other out.
The surface area was calculated for both sectioning angles together and
for each angle separately to show the variation of the estimate with
sectioning angle. The estimate of spine surface area was 1.1 µm2/µm3. (The two sectioning
angles gave 0.88 and 1.3 µm2/µm3 when analyzed
separately.) If the volume of the molecular layer is 0.1 cm3, as suggested above, the total spine surface
area in one rat cerebellum is 0.1 m2.
Light microscopic immunocytochemistry
The regional distribution of staining intensities for EAAT4 was
examined in material treated to have optimal penetration of antibodies.
Therefore the fixation was performed in buffered formaldehyde with
picric acid and low concentrations of glutaraldehyde, and the
immunostaining was performed in the presence of Triton X-100. The
cerebellar molecular layer was intensely stained, whereas all other
brain regions showed staining at background levels (Fig. 4A). The
immunocytochemical procedure used here was not sensitive enough to
detect EAAT4 in the forebrain.

View larger version (86K):
[in this window]
[in a new window]
|
Figure 4.
A, EAAT4 is primarily expressed in
the cerebellar molecular layer. Parasagittal vibratome sections of a
rat brain were incubated with 0.1 µg/ml anti-D537 (rabbit 26900) and
Triton X-100. Note the highly selective staining. B,
High-power view showing the localization of EAAT4 in Purkinje cells.
Triton X-100 was omitted to selectively stain superficial structures
[and the antibody concentration increased (0.3 µg/ml)]. This gives
better clarity but leads to apparently increased staining intensity in
perikarya relative to their dendrites and spines (see Results and Fig.
5C). Scale bars: A, 4 mm;
B, 25 µm. Pu, Purkinje cell.
|
|
To obtain higher resolution for uncovering the cellular
localization, Triton X-100 was omitted (and antibody concentration was
increased). This restricts the neuropil staining mainly to cellular
structures superficial enough to be open to the section surface. At
higher magnification, a large number of densely stained spinous
structures were seen to project from stained dendrites in the molecular
layer (Fig. 4B). The Purkinje cell bodies and their
primary and secondary dendrites were strongly labeled. There was some
labeling of intracellular structures resembling Nissl substance (Fig.
4B). (This type of preparation emphasizes the staining of large diameter structures such as perikarya, in which the
immunoreactants penetrate more deeply into the section than they do in
small diameter structures.) In preparations immunostained with Triton
X-100 (data not shown), large dendrites and perikarya appeared much
less strongly stained than the intervening neuropil. In the latter type
of preparation, perikarya of interneurons could be discerned as empty
spots in the strongly stained molecular layer. The described staining
patterns were obtained with all of the antibodies to EAAT4. Zebrin, in
contrast to EAAT4, was concentrated in the perikarya, large dendrites,
and axons of Purkinje cells (Fig. 5).

View larger version (95K):
[in this window]
[in a new window]
|
Figure 5.
Neighboring 40 µm vibratome sections of rat
cerebellum incubated (in the presence of Triton X-100) with
(A) 0.1 µg/ml anti-A522 to GLAST,
(B) 1:70 dilution of anti-zebrin antibodies,
(C) 0.1 µg/ml anti-D537 to EAAT4,
(D) 0.3 µg/ml anti-C510 to EAAC, or
(E) 0.05 µg/ml anti-B12 to GLT. Note that
parasagittal zones are observed only with antibodies to EAAT4 and
zebrin. Molecular layer (m), granular layer
(g), and white matter (w)
are indicated. Scale bar, 0.3 mm.
|
|
The staining in the cerebellar molecular layer was nonuniform, with
alternating parasagittal zones of high and low staining intensities.
This was not a fixation artifact caused by uneven perfusion, because
the same staining pattern was observed in immersion-fixed tissue (data
not shown). The irregular staining was not observed with antibodies
to GLT, GLAST, and EAAC, but coincided with the banding pattern of
zebrin as shown in adjacent (40-µm-thick) sections stained with the
two antibodies (Fig. 5). Parts of individual Purkinje cells that were
present in both of two adjacent sections were shown to be strongly
immunoreactive for both EAAT4 and zebrin.
Pre-embedding electron microscopy
Parts of sections prepared for light microscopy in the absence of
Triton X-100 were processed for electron microscopy. At the
ultrastructural level, a selective labeling of Purkinje cells was
observed. The spines were strongly immunoreactive (Fig.
6). Nerve terminals synapsing on spines
(parallel fiber terminals as well as climbing fiber terminals) were
unlabeled. No labeling was seen on the cell bodies and processes of
interneurons or glial cells. Even the glial processes ensheathing the
Purkinje cell spines were unlabeled. The labeling of the spines with
the anti-D537 antibodies was restricted to the inner aspects of the
plasma membrane and the adjacent cytoplasm in agreement with the notion
that the C terminals of the glutamate transporters are located
intracellularly.

View larger version (98K):
[in this window]
[in a new window]
|
Figure 6.
Pre-embedding electron microscopic
immunocytochemistry (peroxidase) demonstrates EAAT4 in spinae
(S) of the Purkinje cells in the cerebellar
molecular layer. The nerve terminals (T) are not
stained even when opened by the vibratome knife (asterisk).
The staining intensity is strongest near the cutting surface and
decreases gradually inward into the section. (A spine close to the
scale bar appears negative, probably because of lack of penetration of
the immunoreagents.) The fixed tissue was incubated with 3 µg/ml
rabbit anti-D537 antibodies and processed for immunoperoxidase, before
embedding and cutting of ultrathin sections. Scale bar, 0.26 µm.
A, Astroglial process.
|
|
Postembedding electron microscopy
Having concluded that only Purkinje cells are labeled,
the postembedding immunogold technique was used to determine the
relative differences in immunoreactivity between the different parts of the Purkinje cell membrane. Gold particles were found along the plasmalemma of the Purkinje cells; the highest particle densities appeared along membranes of spines and their parent thin dendrites (Figs. 7-9). This was true whether the
presynaptic element was a parallel fiber (Fig. 7A) or a
climbing fiber (Fig. 7B) bouton. Although the resolution of
the postembedding immunogold method is not sufficient to clearly
distinguish labeling of two apposed cell membranes (Chaudhry et al.,
1995 ), it could be safely concluded, in agreement with the
pre-embedding data, that EAAT4 immunoreactivity was negligible in
membranes other than those of Purkinje cells, because gold particles
were not associated with membranes of axons, parallel fibers, climbing
fibers, basket cells, nerve terminals, astrocytes, and non-Purkinje
cell dendrites and perikarya, unless they were apposed to Purkinje
cells.

View larger version (179K):
[in this window]
[in a new window]
|
Figure 7.
EM postembedding immunogold localization of EAAT4
in the cerebellar molecular layer. Membranes of Purkinje cell spines
(S), spine necks (sn), and
dendrites (D) are labeled whether postsynaptic to
parallel fiber terminals (Pt in A and
C) or (putative) climbing fiber terminals
(Cf in B; containing many microtubules,
mt). Membranes of interneuron dendrites
(I in C), parallel fiber axons
(Pf), and astrocytic (Bergmann fiber) processes
(A) are unlabeled. Arrows in
B indicate labeled intradendritic membranes. Note low
background, e.g., over mitochondria (m). Scale
bar, 500 nm.
|
|
Interestingly, the synaptic membrane and parts of the Purkinje cell
membrane contacting neuronal membranes were far less strongly labeled
than the major portion of the dendritic and spine membrane, which is in
contact with astroglial processes, i.e., of Bergmann fibers (Fig.
8). Membranes of interneurons were not
immunoreactive (Fig. 7C). In profiles of Purkinje cell
dendritic branches, gold particles were often seen to overlie
intracellular membranes (Figs. 7B,
9), in particular multivesicular bodies
(Fig. 9). All of these features were seen in regions of both high and
low levels of EAAT4 immunoreactivity.

View larger version (183K):
[in this window]
[in a new window]
|
Figure 8.
EAAT4 immunoreactivity is concentrated in the
parts of the membranes of Purkinje cell spines
(S) that are in contact
(f) with astroglia
(A). The postsynaptic membranes
(e, lateral borders marked by arrowheads
in A and inset), and the parts of the
spine membrane that are in contact (d) with
presynaptic nerve terminals (T) of parallel
fibers (Pf) rarely show particles
(inset, A). In thin dendrites
(D in B) of Purkinje cells, particles are
concentrated in the parts of the membranes (b)
facing glia (A), avoiding the parts
(a) facing parallel fibers
(Pf). Parallel fiber membranes contacting each
other or glia are unlabeled. Lowercase letters
(a-f) correspond to columns in Figure
11B, showing quantitative analysis. Scale bars,
500 nm.
|
|

View larger version (201K):
[in this window]
[in a new window]
|
Figure 9.
Purkinje cell dendrites (D)
contain EAAT4 immunoreactive multivesicular bodies (mvb)
and intracellular membrane vesicles (arrows), presumably
reflecting trafficking of the transporter protein. Mitochondria
(m) are unlabeled. This dendrite shows several
spine necks (sn). Scale bar, 500 nm.
|
|
In areas displaying high labeling for EAAT4, zebrin immunoreactivity
was present in the Purkinje cell bodies and larger dendrites and could
also be demonstrated in the spines (Fig.
10A,B), confirming that the observations were made on the zebrin-positive bands. This
conclusion was supported by double labeling, showing Purkinje cell
dendrites containing EAAT4 as well as zebrin signal (Fig. 10C). In contrast to EAAT4, zebrin appeared to be located
mainly over cytoplasmic matrix. No zebrin immunoreactivity was
identified in other neuronal structures in the molecular layer apart
from the dendrites of Purkinje cells and a slight signal over Bergmann glia (Fig. 10A,B).

View larger version (177K):
[in this window]
[in a new window]
|
Figure 10.
A, B, Postembedding immunogold
labeling with antibodies to zebrin in a high EAAT4 region. Zebrin is
located over the cytoplasm of Purkinje cell spines
(s), dendrites (D), and to
a lesser degree over Bergmann astroglial processes
(A). Parallel fibers (Pf),
their boutons (T), as well as basket cell
axons (B), containing neurofilaments
(nf in A) are unlabeled.
C, Double labeling for zebrin (10 nm particles:
arrowheads) and EAAT4 (15 nm particles). Zebrin and
EAAT4 are located in the same dendrite (D). The
dendrite membrane has many 15 nm particles where facing astroglial
processes (A), but fewer where facing an
interneuron terminal (T'). (There is a slight background
of 15 nm particles in this preparation). Scale bars, 500 nm.
|
|
The qualitative observations were borne out by quantification (Fig.
11). Spine membranes facing glia had
the highest particle densities. Thin dendrites facing glia had ~60%
of this, whereas the synaptic membranes of Purkinje cell spines, and
the parts of spine membranes facing boutons and other neuronal
processes, had on the order of 10% of the particle densities of spine
membranes facing glia. A clear difference between parts of the
dendritic membrane covered by glia and by neurons was seen also in the
parent thin dendritic branches. The Purkinje cell perikaryal membrane, regardless of neighboring structure, had only 5% of the particle density of the glia-covered spine membrane, and only twice the particle
density of interneuron perikarya. The particle densities along
membranes of interneuron cell bodies and excitatory nerve terminals
(parallel fibers) were of the same order as along mitochondrial outer
membranes, which may be taken as an estimate of background labeling.
The results shown in Figure 11 were from the lower one-third of the
molecular layer in a parasagittal band of high EAAT4 immunoreactivity. Close to the pia, the maximum particle densities were somewhat lower.
However, subpially as well as in a parasagittal band of low EAAT4
immunoreactivity, the rank order of particle densities of the different
categories of structures was the same as in Figure 11. Consistent
results were obtained in less extensive analyses of one more
animal.

View larger version (21K):
[in this window]
[in a new window]
|
Figure 11.
Quantification of EAAT4 immunoreactivity along
different parts of the Purkinje cell membrane. Gold particles per
micrometer of membrane contour length were measured along transected
plasma membrane profiles (high EAAT4 region, lower part of molecular
layer). The results are expressed as mean + SEM. The
numbers of profiles analyzed are given over each column.
The labeling of non-Purkinje cell membranes (black
columns) is similar to background (e.g., mitochondrial outer
membranes in Purkinje cell thin dendrites; 0.074 ± 0.053 particles/µm; mean ± SEM; n = 36).
A, Gold particle densities along interneuron dendrites
(a), Purkinje cell somata
(b), and large dendrites of Purkinje cells
(c), regardless of neighboring structures. (In
c this is almost exclusively glia). B,
Gold particle densities along thin (profile diameter <4 µm) Purkinje
cell dendrites (hatched bars; membrane stretches
a and b in inset sketch)
and Purkinje cell spines (cross-hatched bars; membrane
stretches d, e, and
f), facing either neuronal (a,
d, and e) or glial (b and
f) membranes. Note that the highest
concentrations of EAAT4 are found on Purkinje cell membranes ensheathed
by astrocytes (which express GLT and GLAST). The labeling is low along
the parts of the Purkinje cell membranes facing neurons. It is
negligible in membranes of parallel fiber terminals facing glia
(c). Selected statistical comparisons,
Neuman-Keuls test: B, f > all other categories,
p < 0.00004; B, b > B,
a, p = 0.0002; B, b > A, c, p = 0.04; A,
c > A, b, p = 0.06;
A, c, B, b > B, d, B, e,
p 0.004.
|
|
The particle density of the synaptic membrane was higher than that of
the nerve terminal membrane-facing glia (Fig. 11B,
e and c) in six of seven areas investigated in
two animals (p = 0.028, Wilcoxon matched-pairs
test). Because a region of the spine membrane with low particle density
(d) is interposed between the synaptic site (e)
and the highly labeled parts of the spine membrane (f), the observed synaptic labeling cannot be
ascribed to contamination caused by the limited resolution of the
immunogold method or projection of neighboring structures onto
obliquely cut synaptic sites. [Despite higher particle densities than
the present along nonsynaptic parts of the spine membrane, Tanaka et
al. (1997) found no labeling of the synaptic membrane. However, in the
pre-embedding method used by the latter authors, the immunogold
reagents may not have been able to access antigenic sites within the
postsynaptic density.]
We tested whether the density of EAAT4 in the glia-apposed spine
membrane changed as a function of the distance from the synapse (in the
same material analyzed in Fig. 11B). Longitudinally
sectioned complete spines were selected to avoid errors attributable to oblique sectioning. The first 50 nm segment lateral of the synaptic membrane was excluded to avoid most of the parts of the membrane apposed to nerve terminals (Fig. 11B, d). In 300 nm
bins at increasing distances from the synapse, the particle densities
were 5.6 ± 0.3, 5.3 ± 0.3, and 3.3 ± 0.2, respectively (mean ± SEM; 15 spines), i.e., consistent with a
fairly uniform distribution, declining gradually toward the level of
EAAT4 in the membranes of the thin dendrites between spines (Fig.
11B, b).
Analysis of spine particle density across the border between high and
low EAAT4 regions showed a steep gradient of transition between two
plateaus of particle densities differing by a factor of 3 [5.0 ± 0.30 (mean ± SEM, 77 spines) and 1.6 ± 0.15 (75 spines); p = 0.00001]. Because the number of gold particles per
spine is relatively low and varies stochastically, a number of spines
will appear without gold particles. To try to determine whether there was a population of spines lacking EAAT4, data were accumulated from
the two plateau regions. The histograms (Fig.
12) provided no evidence for the
presence of EAAT4 free spines. In the low EAAT4 region, the number of
spines lacking gold particles was higher than expected for the Poisson
distribution of a random rare event, but the difference was only
borderline significant with the 2 test
(p = 0.04) and nonsignificant with the
Kolmogorov-Smirnov test.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 12.
Variation in labeling of Purkinje cell spines.
Histograms show the particle densities over the glia-covered parts of
the Purkinje cell spine membranes in regions with high
(black) and low (hatched) EAAT4
immunoreactivity.
|
|
Multivesicular bodies had gold particle densities (particles per
micrometer squared) that were on the average an order of magnitude
higher in the EAAT4-rich than in the EAAT4-poor region [229 ± 129 (11) and 27 ± 10 (12) (mean ± SEM, n = dendrite profiles), respectively, compared with 4.9 ± 3.4 (10)
and 3.2 ± 2.2 (12) for the nearest mitochondrion (i.e.,
background estimate)]. Interneurons and Bergmann glia contained no
EAAT4-immunoreactive multivesicular bodies, but the latter had
multivesicular organelles immunoreactive for GLAST.
 |
DISCUSSION |
Antibody specificity
The immunoblots and the peptide preabsorption tests demonstrate
that the anti-D537 antibodies are both highly specific and react with
EAAT4. The latter conclusion is supported by the observation that
protein immunoprecipitated with the sheep anti-D537 is recognized by
both rabbit anti-D537 and rabbit anti-D154 and consistent with the
findings of others using antibodies to residues 1-20 of mouse EAAT4
(Yamada et al., 1996 ) and 550-564 of human EAAT4 (Nagao et al.,
1997 ).
Oligomeric structure of EAAT4
As described previously for GLAST, GLT, and EAAC (Haugeto et al.,
1996 ), cross-linking of EAAT4 before solubilization reveals complexes
of higher molecular masses. It was noted (Haugeto et al., 1996 ) that
GLT is predominantly in trimer form whereas GLAST appears to be a
mixture of dimers and trimers. In this respect it is interesting that
cross-linking of EAAT4 gives rise only to dimer bands. It is noteworthy
that all members of the glutamate transporter family examined so far
(GLAST, GLT, EAAC, and EAAT4) show oligomeric structure, whereas a
member of the other neurotransmitter transporter family, GLYT1, appears
to lack this property (Haugeto et al., 1996 ).
Amount of EAAT4
We found that the surface area of the EAAT4-containing membranes
is 1.1 µm2/µm3 in the
molecular layer. According to published reports (Harvey and Napper,
1988 , 1991 ; Napper and Harvey, 1988 ), one rat cerebellum contains
340,000 Purkinje cells and each Purkinje cell has 165,000 (154,000-175,000) spines, each with a surface of 1.9 µm2 (in mice) (Spacek and Hartmann, 1983 ).
Multiplication of these numbers gives a total spine surface area of 0.1 m2. This value is the same as the one we estimated
(see Results).
By combining our estimate of the EAAT4 content (2 × 10 16 gm in 1 µm3 of
cerebellar molecular layer) with the surface area of the
EAAT4-containing membranes (1.1 µm2/µm3) and assuming that
all the EAAT4 protein is in the membrane, it follows that the average
density of EAAT4 molecules is 1800/µm2 membrane,
because the molecular mass of the polypeptide part of EAAT4 is 61 kDa
(Arriza et al., 1997 ). Because EAAT4 is not evenly distributed, the
concentrations in strongly and weakly labeled zones may be
approximately two times higher or lower than this.
It is important to realize that these numbers represent the total
number of EAAT4 molecules and do not give information on transport
activity. EAAT4 molecules in both plasma membranes and intracellular
membranes are included (although the data suggest that the total amount
of the latter is minor compared with the former). Furthermore, the
turnover number is unknown and the activity of EAAT4 is probably
subject to regulation. Considering these factors, the concentration of
EAAT4 molecules presented here is in good agreement with recent
estimates based on electrophysiological data. Takahashi and coworkers
(1996) calculated that the Purkinje cells contain 1315 EAAT4 carriers
per micrometer squared, whereas Otis and coworkers (1997) predicted
that a postsynaptic transporter, presumably EAAT4, binds at least 880 glutamate molecules per release site (implying that the number of
transporters must be higher since saturation cannot be expected).
The localization of EAAC has so far only been studied with the
pre-embedding peroxidase technique (Rothstein et al., 1994 ), and its
localization is therefore not known in similar detail. Antibodies to
EAAC also label Purkinje cell dendrites. The immunoreactivity on
whole-tissue immunoblots is much weaker than that of EAAT4 (not shown),
suggesting that the average concentration of EAAC is lower (Haugeto et
al., 1996 ). This is in agreement with the assumption that most of the
Purkinje cell postsynaptic glutamate uptake and an even greater
proportion of the synaptic transporter currents may be attributable to
EAAT4 (Otis et al., 1997 ), although it is possible that EAAC has a
higher turnover number (Kataoka et al., 1997 ).
GLAST and GLT have been found only in astroglial membranes, including
those ensheathing the Purkinje cell spines (Chaudhry et al., 1995 ).
Work is currently being performed in our laboratory to quantify these
two proteins also, as well as the total astroglial plasma membrane
surface area. Preliminary data indicate that the cerebellar contents of
GLAST and GLT are several times higher than that of EAAT4 (K. P. Lehre and N. C. Danbolt, unpublished observations).
Localization and functional significance
The net particle density over the postsynaptic membrane
specialization amounts to no more than ~10% of that in the
glia-apposed parts of the spine membrane (Fig. 11). Although there is
relatively little EAAT4 in the Purkinje cell spine membrane immediately
postsynaptic to sites of presynaptic exocytosis, there are large
numbers of EAAT4 transporters <1 µm away in the extrasynaptic
postsynaptic membrane (Figs. 7, 8, 11). Glutamate will diffuse this
distance in <1 msec (Clements, 1996 ), so EAAT4 transporters in
principle should bind glutamate during the falling phase of the
synaptic current at the parallel and climbing fiber synapses onto
Purkinje cells (where the decay time constant of the EPSC is on the
order of 6 msec). Consistent with this, introducing
D-aspartate into Purkinje cells to occupy the EAAT4
glutamate-binding site at the inner membrane surface and thus prevent
external glutamate binding prolongs the decay of the climbing fiber
EPSC (Takahashi et al., 1996 ). Furthermore, by introducing highly
permeant NO3 anion into Purkinje cells
to greatly enhance the current through the anion conductance of EAAT4,
Otis et al. (1997) showed that activation of EAAT4 by synaptically
released glutamate starts at the same time as activation of
postsynaptic AMPA receptors but takes longer to reach a peak.
In view of its location, with larger number of glial transporters
nearby (see above), the uptake function of EAAT4 may seem redundant.
Indeed, glia show a sizable transporter current in response to parallel
fiber stimulation (Clark and Barbour, 1997 ). Yet as much as 20% of the
glutamate released from climbing fibers might be taken up by EAAT4,
based on estimates of quantal content, number of glutamate molecules
per vesicle, synaptic current, and ratio of charge/glutamate flux for
EAAT4 (Otis et al., 1997 ). This significantly curtails the EPSC
duration (Takahashi et al., 1996 ). EAAT4 has a 10-fold higher affinity
for glutamate than has GLAST, GLT, or EAAC (Arriza et al., 1994 ;
Fairman et al., 1995 ), so at low glutamate concentrations EAAT4 could
be active even in the presence of an excess of the other transporters.
Uptake by EAAT4 might also be important in providing Purkinje cells
with glutamate as a precursor for their transmitter GABA.
Despite their perisynaptic location and their binding of synaptically
released glutamate, at low frequencies of climbing or parallel fiber
stimulation EAAT4 transporters are known to contribute negligibly to
the synaptic current, because the EPSC is essentially completely
blocked by the AMPA receptor antagonist CNQX (Konnerth et al., 1990 ;
Perkel et al., 1990 ). Conceivably the anion conductance of EAAT4 might
contribute a significant current when the transporter has been
facilitated by arachidonic acid release (Kataoka et al., 1997 ).
Furthermore, it seems possible that at high frequencies of afferent
action potential, the greater glutamate release that occurs could
activate a significant current through the anion conductance of EAAT4.
Because the reversal potential of the anion conductance is close to the
chloride reversal potential (i.e., below the resting potential, because
activation of GABAA receptors linked to
Cl channels in these cells inhibits
depolarization), this would result in a current opposing the
depolarization caused by glutamate-activating postsynaptic AMPA
receptors and might thus serve as a protective mechanism limiting
excessive Purkinje cell firing.
Future studies are required to unravel the mechanisms regulating the
selective targeting of EAAT4 to specific regions of the membrane of
Purkinje cells, and the different levels of EAAT4 in different cells.
The level of expression of EAAT4 may be an intrinsic property of the
Purkinje cells like their expression of zebrin (aldolase C). The latter
seems to depend on an intrinsic program of differentiation in Purkinje
cells (Seil et al., 1995 ). The expressions of GLAST and GLT appear to
be differentially regulated via glutamate receptors and via novel
neuronal soluble factors, respectively (Gegelashvili et al., 1996 ,
1997 ). In agreement with this, the developmental expression of GLT
seems to depend on intact glutamatergic innervation (Ginsberg et al.,
1995 ; Levy et al., 1995 ) and to follow synaptogenesis (Ullensvang et
al., 1997 ). Corresponding data are not yet available for EAAT4. The
conspicuous presence of EAAT4 in intracellular membranes including
multivesicular bodies is probably a sign of the turning over of
transporter molecules. An interesting possibility is that the
concentration of EAAT4 in the Purkinje cell plasmalemma could be
regulated by transfer to and from intracellular stores. It should be
noted that EAAT4 is present throughout the cerebellar molecular layer.
The light and dark bands represent different levels of expression
rather than an all-or-nothing phenomenon. (The gold particle densities differ by a factor of 3.) The bands correlate with differences in
afferent inputs, but afferents from one site may terminate in both dark
and light bands (Chockkan and Hawkes, 1994 ), and direct functional
comparison of Purkinje cells from zebrin+ and zebrin zones remains to
be performed. Therefore the functional significance of the banding is
unclear. It may be predicted that the Purkinje cells richer in EAAT4
could accept higher frequencies of stimulation via their inputs from
parallel and climbing fibers.
The findings described here give further support to the idea that the
tasks of the glutamate transporters are more sophisticated than simple
transmitter removal.
 |
FOOTNOTES |
Received Oct. 21, 1997; revised March 4, 1998; accepted March 6, 1998.
This work was supported by European Union BIOMED II (contract
BMH4-CT95-0571), Jahrefondet, Odd Fellow medisinsk-vitenskapelig forskningsfond, Rakel og Otto Kr. Bruuns legat, Lars Fylkesakers Stiftelse, Nansenfondet, Schreiners fond, and the Norwegian Research Council. A private donation covered the costs of peptide synthesis. We
thank D. Attwell for discussions and critical reading of this manuscript, G. F. Lothe and C. Knutsen for technical assistance, and R. Hawkes for the gift of antibody to zebrin.
Correspondence should be addressed to N. C. Danbolt, Department of
Anatomy, Institute of Basic Medical Sciences, University of Oslo, P.O.
Box 1105 Blindern, N-0317 Oslo, Norway.
 |
REFERENCES |
-
Ahn AH,
Dziennis S,
Hawkes R,
Herrup K
(1994)
The cloning of zebrin II reveals its identity with aldolase C.
Development
120:2081-2090[Abstract].
-
Arriza JL,
Fairman WA,
Wadiche JI,
Murdoch GH,
Kavanaugh MP,
Amara SG
(1994)
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.
J Neurosci
14:5559-5569[Abstract].
-
Arriza JL,
Eliasof S,
Kavanaugh MP,
Amara SG
(1997)
Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance.
Proc Natl Acad Sci USA
94:4155-4160[Abstract/Free Full Text].
-
Baddeley AJ,
Gundersen HJG,
Cruz-Orive LM
(1986)
Estimation of surface area from vertical sections.
J Microsc
142:259-276[Web of Science][Medline].
-
Barbour B,
Szatkowski M,
Ingledew N,
Attwell D
(1989)
Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells.
Nature
342:918-920[Medline].
-
Barbour B,
Keller BU,
Llano I,
Marty A
(1994)
Prolonged presence of glutamate during excitatory synaptic transmission to cerebellar Purkinje cells.
Neuron
12:1331-1343[Web of Science][Medline].
-
Berod A,
Hartman BK,
Pujol JF
(1981)
Importance of fixation in immunohistochemistry: use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase.
J Histochem Cytochem
29:844-850[Abstract].
-
Blackstad TW,
Karagülle T,
Ottersen OP
(1990)
MORFOREL: a computer program for two dimensional analysis of micrographs of biological specimens with emphasis on immunogold preparations.
Comput Biol Med
20:15-34[Web of Science][Medline].
-
Brochu G,
Maler L,
Hawkes R
(1990)
Zebrin II: a polypeptide antigen expressed selectively by Purkinje cells reveals compartments in rat and fish cerebellum.
J Comp Neurol
291:538-552[Web of Science][Medline].
-
Casado M,
Bendahan A,
Zafra F,
Danbolt NC,
Aragón C,
Giménez C,
Kanner BI
(1993)
Phosphorylation and modulation of brain glutamate transporters by protein kinase C.
J Biol Chem
268:27313-27317[Abstract/Free Full Text].
-
Chaudhry FA,
Lehre KP,
van Lookeren Campagne M,
Ottersen OP,
Danbolt NC,
Storm-Mathisen J
(1995)
Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry.
Neuron
15:711-720[Web of Science][Medline].
-
Chockkan V,
Hawkes R
(1994)
Functional and antigenic maps in the rat cerebellum: zebrin compartmentation and vibrissal receptive fields in lobule IXa.
J Comp Neurol
345:33-45[Web of Science][Medline].
-
Clark BA,
Barbour B
(1997)
Currents evoked in Bergmann glial cells by parallel fibre stimulation in rat cerebellar slices.
J Physiol (Lond)
502:335-350[Abstract/Free Full Text].
-
Clements JD
(1996)
Transmitter timecourse in the synaptic cleft: its role in central synaptic function.
Trends Neurosci
19:163-171[Web of Science][Medline].
-
Conradt M,
Stoffel W
(1997)
Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation.
J Neurochem
68:1244-1251[Web of Science][Medline].
-
Danbolt NC
(1994)
The high affinity uptake system for excitatory amino acid neurotransmitters in the brain.
Prog Neurobiol
44:377-396[Web of Science][Medline].
-
Danbolt NC,
Pines G,
Kanner BI
(1990)
Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain.
Biochemistry
29:6734-6740[Medline].
-
Danbolt NC,
Storm-Mathisen J,
Kanner BI
(1992)
A [Na++K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes.
Neuroscience
51:295-310[Web of Science][Medline].
-
Danbolt NC, Lehre KP, Dehnes Y, Chaudhry FA, Levy
LM (1998) Localization of transporters using
transporter-specific antibodies. Methods Enzymol, in press.
-
Diamond JS,
Jahr CE
(1997)
Transporters buffer synaptically released glutamate on a submillisecond time scale.
J Neurosci
17:4672-4687[Abstract/Free Full Text].
-
Fairman WA,
Vandenberg RJ,
Arriza JL,
Kavanaugh MP,
Amara SG
(1995)
An excitatory amino-acid transporter with properties of a ligand-gated chloride channel.
Nature
375:599-603[Medline].
-
Gegelashvili G,
Civenni G,
Racagni G,
Danbolt NC,
Diemer NH,
Schousboe I,
Schousboe A
(1996)
Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes.
NeuroReport
8:261-265[Web of Science][Medline].
-
Gegelashvili G,
Danbolt NC,
Schousboe A
(1997)
Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia.
J Neurochem
69:2612-2615[Web of Science][Medline].
-
Ginsberg SD,
Martin LJ,
Rothstein JD
(1995)
Regional deafferentation down-regulates subtypes of glutamate transporter proteins.
J Neurochem
65:2800-2803[Web of Science][Medline].
-
Harvey RJ,
Napper RM
(1988)
Quantitative study of granule and Purkinje cells in the cerebellar cortex of the rat.
J Comp Neurol
274:151-157[Web of Science][Medline].
-
Harvey RJ,
Napper RM
(1991)
Quantitative studies on the mammalian cerebellum.
Prog Neurobiol
36:437-463[Web of Science][Medline].
-
Haugeto Ø,
Ullensvang K,
Levy LM,
Chaudhry FA,
Honoré T,
Nielsen M,
Lehre KP,
Danbolt NC
(1996)
Brain glutamate transporter proteins form homomultimers.
J Biol Chem
271:27715-27722[Abstract/Free Full Text].
-
Kanai Y,
Hediger MA
(1992)
Primary structure and functional characterization of a high-affinity glutamate transporter.
Nature
360:467-471[Medline].
-
Kataoka Y,
Morii H,
Watanabe Y,
Ohmori H
(1997)
A postsynaptic excitatory amino acid transporter with chloride conductance functionally regulated by neuronal activity in cerebellar purkinje cells.
J Neurosci
17:7017-7024[Abstract/Free Full Text].
-
Konnerth A,
Llano I,
Armstrong CM
(1990)
Synaptic currents in cerebellar Purkinje cells.
Proc Natl Acad Sci USA
87:2662-2665[Abstract/Free Full Text].
-
Laemmli UK
(1970)
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
-
Lehre KP,
Levy LM,
Storm-Mathisen J,
Ottersen OP,
Danbolt NC
(1995)
Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations.
J Neurosci
15:1835-1853[Abstract].
-
Levy LM,
Lehre KP,
Rolstad B,
Danbolt NC
(1993)
A monoclonal antibody raised against an [Na+ + K+] coupled L-glutamate transporter purified from rat brain confirms glial cell localization.
FEBS Lett
317:79-84[Web of Science][Medline].
-
Levy LM,
Lehre KP,
Walaas SI,
Storm-Mathisen J,
Danbolt NC
(1995)
Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain.
Eur J Neurosci
7:2036-2041[Web of Science][Medline].
-
Lowry OH,
Rosebrough NJ,
Farr AL,
Randall RJ
(1951)
Protein measurement with the Folin phenol reagent.
J Biol Chem
193:265-275[Free Full Text].
-
Marcos P,
Corio M,
Dubourg P,
Covenas R,
Tramu G
(1997)
Double immunocytochemistry in pre-embedding electron microscopy for the detection of neurotensin and tyrosine hydroxylase in the guinea pig, using two primary antisera raised in the same species.
Brain Res Brain Res Protoc
2:1-8.[Medline]
-
Mennerick S,
Zorumski CF
(1994)
Glial contributions to excitatory neurotransmission in cultured hippocampal cells.
Nature
368:59-62[Medline].
-
Müller M, Marti T, Kriz S (1980) Improved structural
preservation by freeze-substitution. Proceedings of the 7th European
Congress on Electron Microscopy 2:720-721.
-
Nagao S,
Kwak S,
Kanazawa I
(1997)
EAAT4, a glutamate transporter with properties of a chloride channel, is predominantly localized in purkinje cell dendrites, and forms parasagittal compartments in rat cerebellum.
Neuroscience
78:929-933[Web of Science][Medline].
-
Napper RM,
Harvey RJ
(1988)
Quantitative study of the Purkinje cell dendritic spines in the rat cerebellum.
J Comp Neurol
274:158-167[Web of Science][Medline].
-
Otis TS,
Kavanaugh MP,
Jahr CE
(1997)
Postsynaptic glutamate transport at the climbing fiber-Purkinje cell synapse.
Science
277:1515-1518[Abstract/Free Full Text].
-
Palay SL,
Chan-Palay V
(1974)
In: Cerebellar cortex: cytology and organization. New York: Springer.
-
Perkel DJ,
Hestrin S,
Sah P,
Nicoll RA
(1990)
Excitatory synaptic currents in Purkinje cells.
Proc R Soc Lond B Biol Sci
241:116-121[Medline].
-
Pines G,
Danbolt NC,
Bjørås M,
Zhang Y,
Bendahan A,
Eide L,
Koepsell H,
Seeberg E,
Storm-Mathisen J,
Kanner BI
(1992)
Cloning and expression of a rat brain L-glutamate transporter.
Nature
360:464-467[Medline].
-
Robinson MB,
Dowd LA
(1997)
Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system.
Adv Pharmacol
37:69-115.
-
Rothstein JD,
Martin L,
Levey AI,
Dykeshoberg M,
Jin L,
Wu D,
Nash N,
Kuncl RW
(1994)
Localization of neuronal and glial glutamate transporters.
Neuron
13:713-725[Web of Science][Medline].
-
Schmitt A,
Asan E,
Puschel B,
Jons T,
Kugler P
(1996)
Expression of the glutamate transporter GLT1 in neural cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry.
Neuroscience
71:989-1004[Web of Science][Medline].
-
Schmitt A,
Asan E,
Puschel B,
Kugler P
(1997)
Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: nonradioactive in situ hybridization and comparative immunocytochemistry.
J Neurosci
17:1-10[Abstract/Free Full Text].
-
Seil FJ,
Johnson ML,
Hawkes R
(1995)
Molecular compartmentation expressed in cerebellar cultures in the absence of neuronal activity and neuron-glia interactions.
J Comp Neurol
356:398-407[Web of Science][Medline].
-
Smith PK,
Krohn RI,
Hermanson GT,
Mallia AK,
Gartner FH,
Provenzano MD,
Fujimoto EK,
Goeke NM,
Olson BJ,
Klenk DC
(1985)
Measurement of protein using bicinchoninic acid.
Anal Biochem
150:76-85[Web of Science][Medline].
-
Somogyi P,
Takagi H
(1982)
A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry.
Neuroscience
7:1779-1783[Web of Science][Medline].
-
Spacek J
(1985a)
Three-dimensional analysis of dendritic spines. II. Spine apparatus and other cytoplasmic components.
Anat Embryol
171:235-243[Medline].
-
Spacek J
(1985b)
Three-dimensional analysis of dendritic spines. III. Glial sheath.
Anat Embryol
171:245-252[Medline].
-
Spacek J,
Hartmann M
(1983)
Three-dimensional analysis of dendritic spines. I. Quantitative observations related to dendritic spine and synaptic morphology in cerebral and cerebellar cortices.
Anat Embryol
167:289-310[Medline].
-
Storck T,
Schulte S,
Hofmann K,
Stoffel W
(1992)
Structure, expression, and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain.
Proc Natl Acad Sci USA
89:10955-10959[Abstract/Free Full Text].
-
Takahashi M,
Kovalchuk Y,
Attwell D
(1995)
Pre- and postsynaptic determinants of EPSC waveform at cerebellar climbing fiber and parallel fiber to Purkinje cell synapses.
J Neurosci
15:5693-5702[Abstract].
-
Takahashi M,
Sarantis M,
Attwell D
(1996)
Postsynaptic glutamate uptake in rat cerebellar Purkinje cells.
J Physiol (Lond)
497:523-530[Abstract/Free Full Text].
-
Tanaka K
(1993)
Expression cloning of a rat glutamate transporter.
Neurosci Res
16:149-153[Web of Science][Medline].
-
Tanaka J,
Ichikawa R,
Watanabe M,
Tanaka K,
Inoue Y
(1997)
Extra-junctional localization of glutamate transporter EAAT4 at excitatory Purkinje cell synapses.
NeuroReport
8:2461-2464[Web of Science][Medline].
-
Tong G,
Jahr CE
(1994)
Block of glutamate transporters potentiates postsynaptic excitation.
Neuron
13:1195-1203[Web of Science][Medline].
-
Towbin H,
Staehelin T,
Gordon J
(1979)
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc Natl Acad Sci USA
76:4350-4354[Abstract/Free Full Text].
-
Trotti D,
Volterra A,
Lehre KP,
Gjesdal O,
Racagni G,
Danbolt NC
(1995)
Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane.
J Biol Chem
270:9890-9895[Abstract/Free Full Text].
-
Trotti D,
Rossi D,
Gjesdal O,
Levy LM,
Racagni G,
Danbolt NC,
Volterra A
(1996)
Peroxynitrite inhibits glutamate transporter subtypes.
J Biol Chem
271:5976-5979[Abstract/Free Full Text].
-
Trotti D,
Rizzini BL,
Rossi D,
Haugeto O,
Racagni G,
Danbolt NC,
Volterra A
(1997)
Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism.
Eur J Neurosci
9:1236-1243[Web of Science][Medline].
-
Ullensvang K,
Lehre KP,
Storm-Mathisen J,
Danbolt NC
(1997)
Differential developmental expression of the two rat brain glutamate transporters GLAST and GLT.
Eur J Neurosci
9:1646-1655[Web of Science][Medline].
-
Vandenberg RJ,
Arriza JL,
Amara SG,
Kavanaugh MP
(1995)
Constitutive ion fluxes and substrate binding domains of human glutamate transporters.
J Biol Chem
270:17668-17671[Abstract/Free Full Text].
-
Wadiche JI,
Amara SG,
Kavanaugh MP
(1995a)
Ion fluxes associated with excitatory amino acid transport.
Neuron
15:721-728[Web of Science][Medline].
-
Wadiche JI,
Arriza JL,
Amara SG,
Kavanaugh MP
(1995b)
Kinetics of a human glutamate transporter.
Neuron
14:1019-1027[Web of Science][Medline].
-
Yamada K,
Watanabe M,
Shibata T,
Tanaka K,
Wada K,
Inoue Y
(1996)
EAAT4 is a post-synaptic glutamate transporter at purkinje cell synapses.
NeuroReport
7:2013-2017[Web of Science][Medline].
-
Zerangue N,
Arriza JL,
Amara SG,
Kavanaugh MP
(1995)
Differential modulation of human glutamate transporter subtypes by arachidonic acid.
J Biol Chem
270:6433-6435[Abstract/Free Full Text].
Copyright © 1998 Society for Neuroscience 0270-6474/98/18103606-14$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Panov, P. Schonfeld, S. Dikalov, R. Hemendinger, H. L. Bonkovsky, and B. R. Brooks
The Neuromediator Glutamate, through Specific Substrate Interactions, Enhances Mitochondrial ATP Production and Reactive Oxygen Species Generation in Nonsynaptic Brain Mitochondria
J. Biol. Chem.,
May 22, 2009;
284(21):
14448 - 14456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jenstad, A. Z. Quazi, M. Zilberter, C. Haglerod, P. Berghuis, N. Saddique, M. Goiny, D. Buntup, S. Davanger, F.-M. S. Haug, et al.
System A Transporter SAT2 Mediates Replenishment of Dendritic Glutamate Pools Controlling Retrograde Signaling by Glutamate
Cereb Cortex,
May 1, 2009;
19(5):
1092 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Brown, G. A. Anderson, K. Son, G. Rentfrow, L. P. Bush, J. L. Klotz, J. R. Strickland, J. A. Boling, and J. C. Matthews
Growing steers grazing high versus low endophyte (Neotyphodium coenophialum)-infected tall fescue have reduced serum enzymes, increased hepatic glucogenic enzymes, and reduced liver and carcass mass
J Anim Sci,
February 1, 2009;
87(2):
748 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ferraguti, L. Crepaldi, and F. Nicoletti
Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives
Pharmacol. Rev.,
December 1, 2008;
60(4):
536 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Torres-Salazar and C. Fahlke
Neuronal Glutamate Transporters Vary in Substrate Transport Rate but Not in Unitary Anion Channel Conductance
J. Biol. Chem.,
November 30, 2007;
282(48):
34719 - 34726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Wersinger, Y. Schwab, J.-A. Sahel, A. Rendon, D. V. Pow, S. Picaud, and M. J. Roux
The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod bipolar cells
J. Physiol.,
November 15, 2006;
577(1):
221 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Blaesse, I. Guillemin, J. Schindler, M. Schweizer, E. Delpire, L. Khiroug, E. Friauf, and H. G. Nothwang
Oligomerization of KCC2 Correlates with Development of Inhibitory Neurotransmission
J. Neurosci.,
October 11, 2006;
26(41):
10407 - 10419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lang, C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms.
Physiol Rev,
October 1, 2006;
86(4):
1151 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Gao, G. Chen, K. C. Reinert, and T. J. Ebner
Cerebellar cortical molecular layer inhibition is organized in parasagittal zones.
J. Neurosci.,
August 9, 2006;
26(32):
8377 - 8387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takayasu, M. Iino, K. Shimamoto, K. Tanaka, and S. Ozawa
Glial glutamate transporters maintain one-to-one relationship at the climbing fiber-Purkinje cell synapse by preventing glutamate spillover.
J. Neurosci.,
June 14, 2006;
26(24):
6563 - 6572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Wadiche, A. V. Tzingounis, and C. E. Jahr
Intrinsic kinetics determine the time course of neuronal synaptic transporter currents
PNAS,
January 24, 2006;
103(4):
1083 - 1087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Melzer, D. Torres-Salazar, and C. Fahlke
A dynamic switch between inhibitory and excitatory currents in a neuronal glutamate transporter
PNAS,
December 27, 2005;
102(52):
19214 - 19218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mim, P. Balani, T. Rauen, and C. Grewer
The Glutamate Transporter Subtypes EAAT4 and EAATs 1-3 Transport Glutamate with Dramatically Different Kinetics and Voltage Dependence but Share a Common Uptake Mechanism
J. Gen. Physiol.,
November 28, 2005;
126(6):
571 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hamann, D. J. Rossi, C. Mohr, A. L. Andrade, and D. Attwell
The electrical response of cerebellar Purkinje neurons to simulated ischaemia
Brain,
October 1, 2005;
128(10):
2408 - 2420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Renden, H. Taschenberger, N. Puente, D. A. Rusakov, R. Duvoisin, L.-Y. Wang, K. P. Lehre, and H. von Gersdorff
Glutamate Transporter Studies Reveal the Pruning of Metabotropic Glutamate Receptors and Absence of AMPA Receptor Desensitization at Mature Calyx of Held Synapses
J. Neurosci.,
September 14, 2005;
25(37):
8482 - 8497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zuo and H. Fang
Glutamate transporter type 3 attenuates the activation of N-methy-D-aspartate receptors co-expressed in Xenopus oocytes
J. Exp. Biol.,
June 1, 2005;
208(11):
2063 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Koch and H. P. Larsson
Small-Scale Molecular Motions Accomplish Glutamate Uptake in Human Glutamate Transporters
J. Neurosci.,
February 16, 2005;
25(7):
1730 - 1736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Huang and A. Bordey
Glial Glutamate Transporters Limit Spillover Activation of Presynaptic NMDA Receptors and Influence Synaptic Inhibition of Purkinje Neurons
J. Neurosci.,
June 23, 2004;
24(25):
5659 - 5669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schniepp, K. Kohler, T. Ladewig, E. Guenther, G. Henke, M. Palmada, C. Boehmer, J. D. Rothstein, S. Broer, and F. Lang
Retinal Colocalization and In Vitro Interaction of the Glutamate Receptor EAAT3 and the Serum- and Glucocorticoid-Inducible Kinase SGK1
Invest. Ophthalmol. Vis. Sci.,
May 1, 2004;
45(5):
1442 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Brasnjo and T. S. Otis
Isolation of glutamate transport-coupled charge flux and estimation of glutamate uptake at the climbing fiber-Purkinje cell synapse
PNAS,
April 20, 2004;
101(16):
6273 - 6278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Huang, M. Dykes-Hoberg, K. Tanaka, J. D. Rothstein, and D. E. Bergles
Climbing Fiber Activation of EAAT4 Transporters and Kainate Receptors in Cerebellar Purkinje Cells
J. Neurosci.,
January 7, 2004;
24(1):
103 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. XU-FRIEDMAN and W. G. REGEHR
Structural Contributions to Short-Term Synaptic Plasticity
Physiol Rev,
January 1, 2004;
84(1):
69 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kinoshita, K. Kimura, N. Matsumoto, M. Watanabe, M. Fukaya, and C. Ide
Mammalian septin Sept2 modulates the activity of GLAST, a glutamate transporter in astrocytes
Genes Cells,
January 1, 2004;
9(1):
1 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Marcaggi, D. Billups, and D. Attwell
The Role of Glial Glutamate Transporters in Maintaining the Independent Operation of Juvenile Mouse Cerebellar Parallel Fibre Synapses
J. Physiol.,
October 1, 2003;
552(1):
89 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. O'Malley, Y.-J. I. Jong, Y. Gonchar, A. Burkhalter, and C. Romano
Activation of Metabotropic Glutamate Receptor mGlu5 on Nuclear Membranes Mediates Intranuclear Ca2+ Changes in Heterologous Cell Types and Neurons
J. Biol. Chem.,
July 18, 2003;
278(30):
28210 - 28219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Voogd, J. Pardoe, T. J. H. Ruigrok, and R. Apps
The Distribution of Climbing and Mossy Fiber Collateral Branches from the Copula Pyramidis and the Paramedian Lobule: Congruence of Climbing Fiber Cortical Zones and the Pattern of Zebrin Banding within the Rat Cerebellum
J. Neurosci.,
June 1, 2003;
23(11):
4645 - 4656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cheng, G. Glover, G. Banker, and S. G. Amara
A Novel Sorting Motif in the Glutamate Transporter Excitatory Amino Acid Transporter 3 Directs Its Targeting in Madin-Darby Canine Kidney Cells and Hippocampal Neurons
J. Neurosci.,
December 15, 2002;
22(24):
10643 - 10652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikegaya, S. Matsuura, S. Ueno, A. Baba, M. K. Yamada, N. Nishiyama, and N. Matsuki
beta -Amyloid Enhances Glial Glutamate Uptake Activity and Attenuates Synaptic Efficacy
J. Biol. Chem.,
August 23, 2002;
277(35):
32180 - 32186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Chaudhry, R. J. Reimer, and R. H. Edwards
The glutamine commute: take the N line and transfer to the A
J. Cell Biol.,
April 29, 2002;
157(3):
349 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wagner, N. Sagiv, and Y. Yarom
GABA-induced current and circadian regulation of chloride in neurones of the rat suprachiasmatic nucleus
J. Physiol.,
December 15, 2001;
537(3):
853 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Reimer, F. A. Chaudhry, A. T. Gray, and R. H. Edwards
Amino acid transport System A resembles System N in sequence but differs in mechanism
PNAS,
June 14, 2000;
(2000)
140152797.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. S. Otis and M. P. Kavanaugh
Isolation of Current Components and Partial Reaction Cycles in the Glial Glutamate Transporter EAAT2
J. Neurosci.,
April 15, 2000;
20(8):
2749 - 2757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Masuda, N. Kakushima, S. G. Wilt, S. K. Ruscetti, P. M. Hoffman, A. Iwamoto, and M. Masuda
Analysis of Receptor Usage by Ecotropic Murine Retroviruses, Using Green Fluorescent Protein-Tagged Cationic Amino Acid Transporters
J. Virol.,
October 1, 1999;
73(10):
8623 - 8629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Chaudhry, R. J. Reimer, E. E. Bellocchio, N. C. Danbolt, K. K. Osen, R. H. Edwards, and J. Storm-Mathisen
The Vesicular GABA Transporter, VGAT, Localizes to Synaptic Vesicles in Sets of Glycinergic as Well as GABAergic Neurons
J. Neurosci.,
December 1, 1998;
18(23):
9733 - 9750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Lehre and N. C. Danbolt
The Number of Glutamate Transporter Subtype Molecules at Glutamatergic Synapses: Chemical and Stereological Quantification in Young Adult Rat Brain
J. Neurosci.,
November 1, 1998;
18(21):
8751 - 8757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Otis and C. E. Jahr
Anion Currents and Predicted Glutamate Flux through a Neuronal Glutamate Transporter
J. Neurosci.,
September 15, 1998;
18(18):
7099 - 7110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Trotti, M. Aoki, P. Pasinelli, U. V. Berger, N. C. Danbolt, R. H. Brown Jr., and M. A. Hediger
Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity
J. Biol. Chem.,
January 5, 2001;
276(1):
576 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Reimer, F. A. Chaudhry, A. T. Gray, and R. H. Edwards
Amino acid transport System A resembles System N in sequence but differs in mechanism
PNAS,
July 5, 2000;
97(14):
7715 - 7720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Chaudhry, R. J. Reimer, and R. H. Edwards
The glutamine commute: take the N line and transfer to the A
J. Cell Biol.,
April 29, 2002;
157(3):
349 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|